...
首页> 外文期刊>Genes, Chromosomes and Cancer >RNA‐sequencing identifies novel GREB1‐NCOA2 GREB1‐NCOA2 fusion gene in a uterine sarcoma with the chromosomal translocation t(2;8)(p25;q13)
【24h】

RNA‐sequencing identifies novel GREB1‐NCOA2 GREB1‐NCOA2 fusion gene in a uterine sarcoma with the chromosomal translocation t(2;8)(p25;q13)

机译:RNA测序用染色体易位T(2; 8)(P25; Q13)鉴定在子宫肉瘤中的新型GREB1-NCOA2 GREB1-NCOB1-NCOA2融合基因(P25; Q13)

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Sarcomas account for 3% of all uterine malignancies and many of them are characterized by acquired, specific fusion genes whose detection has increased pathogenetic knowledge and diagnostic precision. We describe a novel fusion gene, GREB1‐NCOA2 , detected by transcriptome sequencing and validated by reverse transcriptase polymerase chain reaction and Sanger sequencing in an undifferentiated uterine sarcoma. The chimeric transcript was an in‐frame fusion between exon 3 of GREB1 and exon 15 of NCOA2 . The fusion is reported here for the first time, but it involves the GREB1 gene, an important promoter of tumor growth and progression, and NCOA2 which is known to be involved in transcriptional regulation. The alteration and recombination of these genes played a role in the tumorigenesis and/or progression of this sarcoma.
机译:摘要肉瘤占所有子宫恶性肿瘤的3%,其中许多是通过获得的特异性融合基因的特征,其检测具有增加的致病知识和诊断精度。 我们描述了通过转录组测序检测的新型融合基因GreB1-NCOA2,并通过逆转录酶聚合酶链式反应和未分化的子宫肉瘤中的Sanger测序验证。 嵌合转录物是NCOA2的GreB1和外显子15之间的框架融合。 融合是首次报告的,但它涉及GreB1基因,肿瘤生长和进展的重要推动者,并且已知参与转录调控的NCOA2。 这些基因的改变和重组在这种肉瘤的肿瘤鉴定和/或进展中起着作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号